Johnson & Johnson $102.11

down 0.00


28/7/2014 04:00 PM  |  NYSE : JNJ  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get JNJ Trend Analysis - it has underperformed the S&P 500 by 7%

Partner Headlines

  1. BlackRock: Stocks Iffy, But Not These Pockets

    YCharts
  2. YTD Biggest Buyback Companies Trailing S&P In Stock Appreciation

    Benzinga
  3. Just Post-It: 3M Is a Good Bet for Your Portfolio Today

    GuruFocus
  4. Organovo Up 19% #PreMarket; In Research Pact With Johnson & Johnson Unit

    Benzinga
  5. ...

    GuruFocus
  6. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  7. The 10 Most-Respected Corporate Brands

    Benzinga
  8. Stocks To Watch For July 22, 2014

    Benzinga
  9. Why Has Wall Street Punished Johnson & Johnson For Its Earnings Beat?

    Benzinga
  10. #PreMarket Primer: Friday, July 18: Tension Between Russia And The West ...

    Benzinga
  11. Johnson & Johnson CEO: No Plans to Leave U.S.

    FoxBusiness
  12. Which Matters More: Janet Yellen Or Earnings & Economic Data?

    Benzinga
  13. Morgan Stanley Sees Meaningful '15 Headwind For Johnson & Johnson

    Benzinga
  14. Video; J&J Earnings Beat Estimates, But Guidance Mixed

    IBD
  15. Goldman Sachs, JPMorgan Chase Report Strong Earnings; Retail Numbers Fall ...

    Benzinga
  16. U.S. Stocks Sink; JPMorgan Shares Surge On Upbeat Earnings

    Benzinga
  17. J&J Earnings Beat Estimates, But Guidance Mixed

    IBD
  18. Markets Rise; Goldman Sachs Profit Beats Estimates

    Benzinga
  19. Stock Indexes Open Higher, Then Sag To Near Break-Even

    IBD
  20. Johnson & Johnson, Goldman Sachs Pushing These ETFs Upward

    Benzinga
  21. Stock Futures Up Modestly; Goldman, JPMorgan Top Estimates

    IBD
  22. UPDATE: Johnson & Johnson Posts Upbeat Q2 Earnings, Lifts Outlook

    Benzinga
  23. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  24. #PreMarket Primer: Tuesday, July 15: Citigroup Settles Mortgage Probe

    Benzinga
  25. Earnings Scheduled For July 15, 2014

    Benzinga
  26. Stocks To Watch For July 15, 2014

    Benzinga
  27. Benzinga Weekly Preview: Earnings Season Kicks Into High Gear

    Benzinga
  28. J.P. Morgan: Johnson & Johnson's Drug Segment May Beat Q2 Street Views

    Benzinga
  29. The Power of a Photo Op, Or Lack Thereof

    FoxBusiness
  30. Celgene Drug Otezla Fails Trial, But Street Sanguine

    IBD
  31. Warmer Weather Improving Q2 Earnings Forecasts

    IBD
  32. Merck, Gilead Lead Race To Eradicate Hepatitis C

    IBD
  33. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  34. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  35. Markets Little Changed As The Quarter Comes To An End

    Benzinga
  36. Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To ...

    Benzinga
  37. Bristol-Myers, Pfizer, Regeneron Drugs Get EU Nods

    IBD
  38. British Stocks: Sweet Spot For European Value

    YCharts
  39. Top Five Mega-Cap Stocks That Gurus Like

    GuruFocus
  40. Pharma Sector Stocks To Consider For Sustained Returns

    GuruFocus
  41. Running an Offense or Defense?

    GuruFocus
  42. The Split That Makes Me Want More

    GuruFocus
  43. Metric Measures Quality: And Then There’s Price

    YCharts
  44. Dow, S&P 500 End At New Highs, Led By Auto Retailers

    IBD
  45. Dow, S&P 500 Hit All-Time Highs As Volume Swells

    IBD
  46. Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech ...

    Benzinga
  47. Drugs Drive Growth For Johnson & Johnson

    IBD
  48. Medtronic-Covidien Deal Says Size Matters In Devices

    IBD
  49. Investors May Add Johnson & Johnson to Their Portfolio

    GuruFocus
  50. Medtronic Buying Covidien, Becoming Device Colossus

    IBD
Trading Center